Free Trial

Danaher (DHR) Stock Forecast & Price Target

Danaher logo
$228.55 +2.39 (+1.06%)
(As of 12/20/2024 05:45 PM ET)

Danaher - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
15

Based on 19 Wall Street analysts who have issued ratings for Danaher in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, and 15 have given a buy rating for DHR.

Consensus Price Target

$288.21
26.10% Upside
According to the 19 analysts' twelve-month price targets for Danaher, the average price target is $288.21. The highest price target for DHR is $315.00, while the lowest price target for DHR is $250.00. The average price target represents a forecasted upside of 26.10% from the current price of $228.55.
Get the Latest News and Ratings for DHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Danaher and its competitors.

Sign Up

DHR Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
14 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
Hold
4 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$288.21$287.16$278.94$259.40
Forecasted Upside26.10% Upside22.32% Upside2.31% Upside12.61% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

DHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Danaher Stock vs. The Competition

TypeDanaherMulti-Sector Conglomerates CompaniesS&P 500
Consensus Rating Score
2.79
2.65
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside26.10% Upside25.51% Upside14.54% Upside
News Sentiment Rating
Positive News

See Recent DHR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/19/2024Guggenheim
2 of 5 stars
S. Nambi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$275.00+20.46%
12/13/2024Bank of America
3 of 5 stars
 UpgradeNeutral ➝ Buy$290.00 ➝ $290.00+23.67%
10/31/2024Wolfe Research
3 of 5 stars
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$285.00+17.61%
10/23/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$310.00 ➝ $315.00+23.29%
10/23/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$333.00 ➝ $311.00+21.73%
10/23/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Johnson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$315.00 ➝ $315.00+23.29%
10/23/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$309.00 ➝ $305.00+19.66%
10/23/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$250.00 ➝ $265.00+3.97%
10/23/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$310.00 ➝ $300.00+16.48%
10/23/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$290.00 ➝ $310.00+19.45%
10/23/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$285.00 ➝ $275.00+5.25%
10/23/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$278.00 ➝ $277.00+6.02%
10/1/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
V. Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$275.00 ➝ $278.00+1.41%
8/27/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$280.00+4.16%
7/24/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$275.00 ➝ $280.00+5.22%
7/24/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$225.00 ➝ $250.00-6.32%
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$295.00+13.35%
4/24/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$280.00 ➝ $290.00+16.02%
4/17/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$250.00 ➝ $280.00+16.93%
12/20/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$250.00 ➝ $270.00+17.71%
5/1/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$300.00+26.63%
4/27/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$310.00 ➝ $275.00+18.29%
4/26/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Larew
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/26/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$300.00 ➝ $270.00+16.38%
1/25/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$340.00 ➝ $320.00+17.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:32 PM ET.


Should I Buy Danaher Stock? DHR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Danaher pros and cons to contact@marketbeat.com.

Danaher
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Danaher Co.:

  • Danaher Co. recently reported earnings per share (EPS) of $1.71, exceeding analysts' expectations of $1.57, indicating strong financial performance and effective management.
  • The company has a solid market capitalization of approximately $166.21 billion, reflecting its stability and significant presence in the market.
  • Danaher Co. has a current stock price of $230.12, which is a reasonable entry point considering its potential for growth, as indicated by a consensus target price of $287.16.
  • With a net margin of 16.39%, Danaher Co. demonstrates efficient cost management and profitability, which can lead to higher returns for investors.
  • The company has a low debt-to-equity ratio of 0.32, suggesting a conservative approach to leverage and financial risk, which can be appealing to risk-averse investors.

Danaher
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Danaher Co. for these reasons:

  • Recent downgrades from analysts, including a cut from "buy" to "hold" by StockNews.com, may indicate a lack of confidence in the stock's short-term performance.
  • The stock has experienced a decline from its 52-week high of $281.70, which could signal potential volatility and risk for investors looking for stable returns.
  • Danaher Co. has a relatively high price-to-earnings (P/E) ratio of 43.97, which may suggest that the stock is overvalued compared to its earnings, making it less attractive for value investors.
  • Analysts have mixed opinions on the stock, with some lowering their price targets, which could create uncertainty about its future performance.
  • The company’s quarterly revenue growth of only 3.1% year-over-year may not meet the expectations of investors seeking rapid growth, potentially limiting its appeal.

DHR Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Danaher is $288.21, with a high forecast of $315.00 and a low forecast of $250.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DHR shares.

According to analysts, Danaher's stock has a predicted upside of 26.10% based on their 12-month stock forecasts.

Over the previous 90 days, Danaher's stock had 2 upgrades by analysts.

Analysts like Danaher more than other "multi-sector conglomerates" companies. The consensus rating score for Danaher is 2.79 while the average consensus rating score for "multi-sector conglomerates" companies is 2.65. Learn more on how DHR compares to other companies.


This page (NYSE:DHR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners